P-glycoprotein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy

L Kostakoglu, D Guc, H Canpinar… - The Journal of Nuclear …, 1998 - search.proquest.com
Our aim was to ascertain the relationship between the degree of 99mTc-MIBI uptake and the
level of p-glycoprotein (Pgp) expression determined by flow cytometry and reverse …

Assessment of the P-glycoprotein expression by 99mTc-MIBI bone marrow imaging in patients with untreated leukaemia

I Ak, V Aslan, E Vardareli… - Nuclear medicine …, 2003 - journals.lww.com
The ability of cancer cells to become simultaneously resistant to different drugs is a
significant impediment to successful chemotherapy. 99m Tc-MIBI has been reported to be a …

Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer

L Kostakoglu, P Kirath, S Ruacan… - The Journal of Nuclear …, 1998 - search.proquest.com
Expression of P-Glycoprotein in Lung Cancer Page 1 Association of Tumor Washout Rates
and Accumulation of Technetium-99m-MIBI with Expression of P-Glycoprotein in Lung Cancer …

The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors

Z Yapar, M Kibar, AF Yapar, A Uguz, S Ozbarlas… - Annals of nuclear …, 2003 - Springer
P-glycoprotein (Pgp) overexpression has been shown to be correlated with resistance to
chemotherapy in patients with malignant bone and soft-tissue tumors. The aim of our study …

[PDF][PDF] Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer

L Kostakoglu, S Ruacan, EL Ergün… - Journal of Nuclear …, 1998 - Soc Nuclear Med
(B)++ strong; and (C) F+(arrows) focalp-glycoproteinstaining. Corresponding@ †œTc-MlBl
imagingonthispatientisshowninFigure3k Patient2:(D)++ strong;(E)+ weak; and (F) …

[PDF][PDF] Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy

J Taki, H Sumiya, N Asada, Y Ueda… - Journal of Nuclear …, 1998 - Soc Nuclear Med
MATERIALS AND METhODS Patients Our study comprised 30 patients with various
malignant bone and soft-tissue tumors proven pathologically by specimens ob tamed from …

Experimental and clinical observations of 99mTc-MIBI uptake correlate with P-glycoprotein expression in lung cancer

A Yang, J Xue, X Li, Y Yu, H Deng, G Hu… - Nuclear Medicine …, 2007 - journals.lww.com
Background 99m Tc-methoxyisobutylisonitrile (99m Tc-MIBI) has been used as a tumour
positive scintigraphic agent for diagnostic purposes. However, the pharmaceutical kinetics …

99mTc-MIBI scintigraphy in metastatic renal cell carcinoma: clinical validation of the relationship between99mTc-MIBI uptake and P-alvcoprotein expression in …

E Derebek, Z Kirkali, AS Dogan, B Degirmenci… - European journal of …, 1996 - Springer
Abstract Technetium-99m hexakis-2-methoxyisobutyl-isonitrile (MIBI) and thallium-201
imaging was performed in a patient with metastatic renal cell carcinoma (RCC), which is a …

Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma

HC Song, JJ Lee, HS Bom, IJ Chung… - Clinical nuclear …, 2003 - journals.lww.com
Purpose Tc-99m MIBI is a promising agent for the functional characterization of P-
glycoprotein expression and the prediction of therapeutic outcome in human tumors. The …

Functional retention of Tc-99m MIBI in mediastinal lymphomas as a predictor of chemotherapeutic response demonstrated by consecutive thoracic SPECT imaging

WJ Shih, A Rastogi, V Stipp, S Magoun… - Clinical nuclear …, 1998 - journals.lww.com
Tc-99m MIBI is used as a tumor imaging agent and has been proposed to measure p-
glycoprotein function, which plays an important role in tumor multidrug resistance to …